HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3.

Abstract
Recent decades have seen a significant increase in the incidence of diabetes mellitus. The number of individuals with diabetes is projected to reach 300 million by the year 2025. Diabetes is a leading cause of blindness, renal failure, lower limb amputation, and an independent risk factor for atherosclerotic cardiovascular disease (CVD)--a leading cause of death in Western society. Understanding the molecular and cellular mechanisms by which diabetes mellitus promotes atherosclerosis is essential to developing methods to treat and prevent diabetes-associated CVD. This review summarizes our current knowledge of the mechanisms by which diabetes may promote atherogenesis and specifically focuses on a novel pathway linking these 2 conditions. We hypothesize that the accumulation of intracellular glucosamine observed in conditions of chronic hyperglycaemia may promote atherogenesis via a mechanism involving dysregulated protein folding, activation of endoplasmic reticulum (ER) stress, and increased glycogen synthase kinase (GSK)-3 activity. The identification of this novel mechanism provides a promising hypothesis and multiple new targets for potential therapeutic intervention in the treatment of diabetes mellitus and accelerated atherosclerosis.
AuthorsLindsie A Robertson, Anna J Kim, Geoff H Werstuck
JournalCanadian journal of physiology and pharmacology (Can J Physiol Pharmacol) Vol. 84 Issue 1 Pg. 39-48 (Jan 2006) ISSN: 0008-4212 [Print] Canada
PMID16845889 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Protein Kinase Inhibitors
  • Glycogen Synthase Kinase 3
Topics
  • Animals
  • Atherosclerosis (metabolism)
  • Diabetes Complications (metabolism)
  • Diabetes Mellitus (metabolism)
  • Endoplasmic Reticulum (metabolism)
  • Glycogen Synthase Kinase 3 (antagonists & inhibitors, metabolism)
  • Humans
  • Hyperglycemia (complications, metabolism)
  • Protein Kinase Inhibitors (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: